Prioritisation has to be done on criteria for COVID-19 vaccination
First Published: 27th October, 2020 21:45 IST
Amid claims of various state governments that it would provide free COVID-19 vaccinations, the Union government’s expert group on vaccines on Tuesday said that they should wait for a clearer
Amid claims of various state governments that it would provide free COVID-19 vaccinations, the Union government’s expert group on vaccines on Tuesday said that they should wait for a clearer picture to emerge on vaccine prioritisation.
“We’ve requested state governments to wait for an overall picture to become clear ad to take a national approach towards engaging companies, and deciding the criteria for the vaccine. Prioritisation has to be done,” Dr VK Paul, Member (Health), NITI Aayog and chairperson of Covid-19 taskforce committee said on Tuesday while addressing a Union Health Ministry’s press conference.
He also said that at present there is no vaccine in the world and that it is fortunate that trials are being done on Indian soil.
“We are working to look at our approach to vaccine implementation. As and when vaccines are available, and in that regard, the access to vaccines will be in such a way that vaccine supply is not unlimited. Prioritisation has to be done. The prioritisation principles will be determined on the basis of availability of the vaccine, who should be getting that vaccine,” he stated.
Dr Paul added that discussions in the committee of Union Government are being conducted and blueprints are being finalized and added that committee and oversee that in order to deliver the vaccine to priority groups, there will be no problems in terms of resources.
Dr Balram Bhargava, Director General (DG) of the Indian Council of Medical Research (ICMR) who was also present in the media meet informed that currently, three vaccines are in different stages of trial in India.
“There are three vaccine candidates in different stages of clinical testing- Covaxin has got approval for phase III trials, Cadila also progressing with phase-II trials & Serum is completing phase 2b trial and has an ongoing trial in Brazil, South Africa, and the US,” said Dr Bhargava. (ANI)
COMMENTS
TOPMOST STORY NOW
Live Kuki, Meitei CSOs Likely to Meet Again Later This Month
05th April 2025
Live Sikkim Premier League Season 3 to Kick Off From April 10 in Namchi
05th April 2025
Live Meghalaya SSLC 2025 Results Out: Records Historic 87.10% Pass Rate
05th April 2025
Live Konyak Culture a Symbol of Resilience and Artistry: MoS Dr. Sukanta Majumdar at Mon Heritage Site Inauguration
05th April 2025
WE RECOMMEND
Parliament passes 16 bills during budget session
During this Session a total of 11 Bills (10 in Lok Sabha and 1 in Rajya Sabha) were introduced.
05th April 2025
Is Uploading Your Photo to AI Image Generators Including Ghibli-Style a Privacy Risk? Here’s How to Keep Your Biometric Data Safe
Ghibli-Style Image ChatGPT: As AI trends continue to grow, it is essential to stay alert about the potential risks.
02nd April 2025
A Sacred Journey, A Compassionate Heart: Anant Ambani Stops His Padayatra to Save Trapped Hens
Anant Ambani Stops His Padayatra to Save Trapped Hens: Anant Ambani seen holding a hen in front of a cage containing several trapped birds.
01st April 2025
Who is Nidhi Tewari Appointed Private Secretary to PM Modi?
Nidhi Tewari hails from Mehmurganj in Varanasi, Uttar Pradesh, which has been PM Narendra Modi's parliamentary constituency since 2014
01st April 2025
India hands over 50 tons of relief material to Myanmar
More than 2,000 people are now confirmed dead in Myanmar.
01st April 2025